ATE488253T1 - Verfahren zum nachweis eines fibringerinnsels - Google Patents

Verfahren zum nachweis eines fibringerinnsels

Info

Publication number
ATE488253T1
ATE488253T1 AT98934690T AT98934690T ATE488253T1 AT E488253 T1 ATE488253 T1 AT E488253T1 AT 98934690 T AT98934690 T AT 98934690T AT 98934690 T AT98934690 T AT 98934690T AT E488253 T1 ATE488253 T1 AT E488253T1
Authority
AT
Austria
Prior art keywords
detecting
source
particles
fibring
clot
Prior art date
Application number
AT98934690T
Other languages
English (en)
Inventor
Chenicheri Nair
Elena Shats
William Burch
Rodney Browitt
Timothy Senden
Original Assignee
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Australian filed Critical Univ Australian
Application granted granted Critical
Publication of ATE488253T1 publication Critical patent/ATE488253T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A61K51/1251—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles micro- or nanospheres, micro- or nanobeads, micro- or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
AT98934690T 1997-07-24 1998-07-23 Verfahren zum nachweis eines fibringerinnsels ATE488253T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/AU1997/000467 WO1999004826A1 (en) 1997-07-24 1997-07-24 Method for detection of fibrin clots
PCT/AU1998/000582 WO1999004827A1 (en) 1997-07-24 1998-07-23 Method for detection of fibrin clots

Publications (1)

Publication Number Publication Date
ATE488253T1 true ATE488253T1 (de) 2010-12-15

Family

ID=3764343

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98934690T ATE488253T1 (de) 1997-07-24 1998-07-23 Verfahren zum nachweis eines fibringerinnsels

Country Status (8)

Country Link
US (1) US6977068B1 (de)
EP (1) EP1027080B1 (de)
JP (1) JP3943330B2 (de)
AT (1) ATE488253T1 (de)
AU (2) AU3532197A (de)
CA (1) CA2297399C (de)
DE (1) DE69842003D1 (de)
WO (2) WO1999004826A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3532197A (en) 1997-07-24 1999-02-16 Australian National University, The Method for detection of fibrin clots
WO2000078362A2 (de) * 1999-06-22 2000-12-28 Aventis Research & Technologies Gmbh & Co. Kg Stabile radioaktiv markierte nanopartikel, verfahren zur herstellung und ihrer verwendung
US6689338B2 (en) * 2000-06-01 2004-02-10 The Board Of Regents For Oklahoma State University Bioconjugates of nanoparticles as radiopharmaceuticals
AU2006243805B2 (en) * 2005-04-29 2012-02-02 The Australian National University A method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate
WO2006116798A1 (en) 2005-04-29 2006-11-09 The Australian National University A method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate
AU2006200755B2 (en) * 2005-07-11 2011-02-10 Cyclomedica Australia Pty Limited Improved process for the production of a radioactive aerosol
AU2009240790C1 (en) * 2008-04-24 2015-04-16 The Australian National University Methods for radiolabelling synthetic polymers
CA2721836C (en) * 2008-04-24 2017-04-11 The Australian National University Methods for radiolabelling macromolecules
DE102009015792A1 (de) * 2009-03-23 2010-09-30 Technische Universität Dresden Mittel für die Diagnose der Lungenfunktion mittels Positronen-Emissions-Tomographie
GB0922497D0 (en) * 2009-12-23 2010-02-03 Hammersmith Imanet Ltd Preparation and use of 68GA labelled particles
KR101956335B1 (ko) 2010-12-01 2019-03-08 디 오스트레일리언 내셔널 유니버시티 히스톤 억제
US10779855B2 (en) 2011-08-05 2020-09-22 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
EP4101399B1 (de) 2011-08-05 2025-04-09 Route 92 Medical, Inc. System zur behandlung eines akuten ischämischen schlaganfalls
US9265512B2 (en) 2013-12-23 2016-02-23 Silk Road Medical, Inc. Transcarotid neurovascular catheter
US11065019B1 (en) 2015-02-04 2021-07-20 Route 92 Medical, Inc. Aspiration catheter systems and methods of use
CA2983072A1 (en) 2015-02-04 2016-08-11 Route 92 Medical, Inc. Rapid aspiration thrombectomy system and method
WO2017019563A1 (en) 2015-07-24 2017-02-02 Route 92 Medical, Inc. Anchoring delivery system and methods
US10716915B2 (en) 2015-11-23 2020-07-21 Mivi Neuroscience, Inc. Catheter systems for applying effective suction in remote vessels and thrombectomy procedures facilitated by catheter systems
EP3419528B1 (de) 2016-02-24 2023-06-07 Incept, LLC Neurovaskulärer katheter mit erhöhter flexibilität
CN110381855B (zh) 2017-01-06 2023-07-04 因赛普特有限责任公司 用于动脉瘤治疗装置的抗血栓涂层
CN120168816A (zh) 2017-01-10 2025-06-20 92号医疗公司 导管、血管内导管前进装置及系统
EP3570928A1 (de) 2017-01-20 2019-11-27 Route 92 Medical, Inc. Einbedienersysteme zur intrakraniellen freisetzung von medizinprodukten und verfahren zur verwendung
US11395665B2 (en) 2018-05-01 2022-07-26 Incept, Llc Devices and methods for removing obstructive material, from an intravascular site
WO2019212984A1 (en) 2018-05-01 2019-11-07 Imperative Care, Inc. Devices and methods for removing obstructive material from an intravascular site
EP3793660B1 (de) 2018-05-17 2024-11-13 Route 92 Medical, Inc. Aspirationskathetersysteme
US11471582B2 (en) 2018-07-06 2022-10-18 Incept, Llc Vacuum transfer tool for extendable catheter
US11517335B2 (en) 2018-07-06 2022-12-06 Incept, Llc Sealed neurovascular extendable catheter
US11766539B2 (en) 2019-03-29 2023-09-26 Incept, Llc Enhanced flexibility neurovascular catheter
CN113347916B (zh) 2019-10-15 2025-04-25 因普瑞缇夫护理公司 用于多变量卒中检测的系统和方法
JP2023507553A (ja) 2019-12-18 2023-02-24 インパラティブ、ケア、インク． 静脈血栓塞栓症を治療するための方法及びシステム
US11633272B2 (en) 2019-12-18 2023-04-25 Imperative Care, Inc. Manually rotatable thrombus engagement tool
US11259821B2 (en) 2019-12-18 2022-03-01 Imperative Care, Inc. Aspiration system with accelerated response
CN113747934B (zh) 2020-03-10 2024-07-09 因普瑞缇夫护理公司 增强的柔韧性的神经血管导管
US11207497B1 (en) 2020-08-11 2021-12-28 Imperative Care, Inc. Catheter with enhanced tensile strength
WO2022076893A1 (en) 2020-10-09 2022-04-14 Route 92 Medical, Inc. Aspiration catheter systems and methods of use
US12558175B2 (en) 2021-08-12 2026-02-24 Imperative Care, Inc. Multi catheter method of performing a robotic neurovascular procedure
USD1077996S1 (en) 2021-10-18 2025-06-03 Imperative Care, Inc. Inline fluid filter

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1243784A (en) * 1984-10-04 1988-10-25 William M. Burch Radionuclide metallic vapour
US5217705A (en) * 1987-09-25 1993-06-08 Neorx Corporation Method of diagnosing blood clots using fibrin-binding proteins
US5330768A (en) * 1991-07-05 1994-07-19 Massachusetts Institute Of Technology Controlled drug delivery using polymer/pluronic blends
US5248498A (en) * 1991-08-19 1993-09-28 Mallinckrodt Medical, Inc. Fullerene compositions for magnetic resonance spectroscopy and imaging
GB9203037D0 (en) * 1992-02-11 1992-03-25 Salutar Inc Contrast agents
CA2147129A1 (en) * 1992-10-27 1994-05-11 James B. Doherty New substituted azetidinones as anti-inflammatory and antidegenerative agents
AU686861B2 (en) * 1994-09-21 1998-02-12 Allrad No. 28 Pty Ltd A precipitator
DE19506188C2 (de) * 1995-02-22 2003-03-06 Miladin Lazarov Implantat und dessen Verwendung
US5640705A (en) * 1996-01-16 1997-06-17 Koruga; Djuro L. Method of containing radiation using fullerene molecules
AU3532197A (en) 1997-07-24 1999-02-16 Australian National University, The Method for detection of fibrin clots

Also Published As

Publication number Publication date
AU744489B2 (en) 2002-02-28
US6977068B1 (en) 2005-12-20
EP1027080A1 (de) 2000-08-16
WO1999004827A1 (en) 1999-02-04
JP3943330B2 (ja) 2007-07-11
HK1027041A1 (en) 2001-01-05
AU8425998A (en) 1999-02-16
JP2001510812A (ja) 2001-08-07
AU3532197A (en) 1999-02-16
CA2297399C (en) 2007-07-03
WO1999004826A1 (en) 1999-02-04
EP1027080B1 (de) 2010-11-17
EP1027080A4 (de) 2004-07-14
DE69842003D1 (de) 2010-12-30
CA2297399A1 (en) 1999-02-04

Similar Documents

Publication Publication Date Title
ATE488253T1 (de) Verfahren zum nachweis eines fibringerinnsels
DE69816829D1 (de) Verfahren zur erkennung von lecken in rohrleitungen
DE69017636D1 (de) Detektierbarer Gegenstand zur unterirdischen Anwendung und Verfahren zu seiner Lokalisierung.
ATE373822T1 (de) Verfahren zur detektion von markierstoffen in kohlenwasserstoffen und kohlenwasserstoffgemischen
DE69915926D1 (de) Verfahren und Echographiegerät zur Erfassung von Elastizitätsveränderungen
DE69939495D1 (de) Verfahren und system zum testen von computercodes
DE60021216D1 (de) Vorrichtung zur Wiedergabe von Musik, Verfahren zur Taktierungsanalyse und Speichermedium
DE69701314D1 (de) Schlauch und verfahren zur entdeckung von abnutzung
DE59805321D1 (de) Verfahren und anordnung zum erkennen von verteilinformationen
DE69513248D1 (de) Zusammensetzung, Verfahren und System zum Nachweis von Leukocyten, Esterasen oder Proteasen in einer Testprobe
ATE225039T1 (de) Volumenunabhängiger diagnostischer testträger und verfahren zur bestimmung von analyten mit dessen hilfe
ATE225937T1 (de) Diagnostischer testträger mit mehrschichtigem testfeld und verfahren zur bestimmung von analyten mit dessen hilfe
DE69710523D1 (de) Verfahren und Vorrichtung zum Detektieren von Eisenbahnaktivität
DE69826583D1 (de) Vorrichtung und Verfahren zum Erreichen von klinischen wichtigen Analytverhältnissen
DE60122786D1 (de) System und verfahren zum kommentieren von medizinischen patienteninformationen
DE69534301D1 (de) Kulturmedium und vorrichtung zum nachweis und zur quantifizierung von enterobakteriaceae
DE69520004D1 (de) Verfahren zum feststellen und/oder zum identifizieren von mikrobenkolonien
DE69806802D1 (de) Verfahren zur unterscheidung von erythroblasten
DE69804251D1 (de) Verfahren und vorrichtung zum zementieren von futterrohren in bohrlöchern
DE69709087D1 (de) Verfahren zum nachweis und zur identifizierung von mikroorganismen
DE60023779D1 (de) Vorrichtung und Verfahren zur Überblendungsdetektion und Überblendungsinformationscodierung
DE69203640D1 (de) Unsichtbare Kennzeichen für Petroleum, Verfahren zur Markierung und Verfahren zum Nachweisen.
DE69834493D1 (de) Verfahren und gerät zum nachweis und zur zählung von mikroorganismen
DE69927871D1 (de) Vorrichtung und Verfahren zur Unterscheidung von Erythrozyten in Urin
DE69918123D1 (de) Verfahren und reagentiensatz zur erkennung von protein-protein wechselwirkungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties